Legend Biotech (LEGN) Competitors $36.08 +1.09 (+3.12%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$36.16 +0.08 (+0.23%) As of 09/5/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LEGN vs. TEVA, SMMT, GMAB, VTRS, RDY, ASND, QGEN, MRNA, BBIO, and VRNAShould you be buying Legend Biotech stock or one of its competitors? The main competitors of Legend Biotech include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), QIAGEN (QGEN), Moderna (MRNA), BridgeBio Pharma (BBIO), and Verona Pharma PLC American Depositary Share (VRNA). These companies are all part of the "pharmaceutical products" industry. Legend Biotech vs. Its Competitors Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Dr. Reddy's Laboratories Ascendis Pharma A/S QIAGEN Moderna BridgeBio Pharma Verona Pharma PLC American Depositary Share Teva Pharmaceutical Industries (NYSE:TEVA) and Legend Biotech (NASDAQ:LEGN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings. Which has more risk & volatility, TEVA or LEGN? Teva Pharmaceutical Industries has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Legend Biotech has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Does the media refer more to TEVA or LEGN? In the previous week, Teva Pharmaceutical Industries had 17 more articles in the media than Legend Biotech. MarketBeat recorded 24 mentions for Teva Pharmaceutical Industries and 7 mentions for Legend Biotech. Teva Pharmaceutical Industries' average media sentiment score of 1.31 beat Legend Biotech's score of 0.88 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 15 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Legend Biotech 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of TEVA or LEGN? 54.1% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 70.9% of Legend Biotech shares are held by institutional investors. 0.5% of Teva Pharmaceutical Industries shares are held by company insiders. Comparatively, 0.0% of Legend Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend TEVA or LEGN? Teva Pharmaceutical Industries currently has a consensus price target of $24.71, suggesting a potential upside of 30.51%. Legend Biotech has a consensus price target of $74.22, suggesting a potential upside of 105.72%. Given Legend Biotech's higher probable upside, analysts clearly believe Legend Biotech is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Legend Biotech 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91 Is TEVA or LEGN more profitable? Teva Pharmaceutical Industries has a net margin of -0.95% compared to Legend Biotech's net margin of -40.83%. Teva Pharmaceutical Industries' return on equity of 46.10% beat Legend Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-0.95% 46.10% 7.18% Legend Biotech -40.83%-32.00%-20.07% Which has better valuation and earnings, TEVA or LEGN? Legend Biotech has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Legend Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.54B1.31-$1.64B-$0.16-118.35Legend Biotech$627.24M10.62-$177.03M-$0.88-41.00 SummaryTeva Pharmaceutical Industries beats Legend Biotech on 11 of the 17 factors compared between the two stocks. Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LEGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LEGN vs. The Competition Export to ExcelMetricLegend BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.66B$3.18B$5.83B$9.93BDividend YieldN/A2.27%6.70%4.52%P/E Ratio-41.0021.1076.1526.11Price / Sales10.62466.44562.61123.62Price / CashN/A45.7236.9959.28Price / Book6.339.8711.486.09Net Income-$177.03M-$53.42M$3.29B$266.51M7 Day Performance3.89%2.93%1.27%0.46%1 Month Performance-4.20%9.85%7.94%4.59%1 Year Performance-25.28%15.74%62.94%26.04% Legend Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LEGNLegend Biotech3.3574 of 5 stars$36.08+3.1%$74.22+105.7%-33.2%$6.66B$627.24M-41.002,609TEVATeva Pharmaceutical Industries3.4637 of 5 stars$18.14-1.7%$24.71+36.2%+2.7%$21.17B$16.54B7.3836,830News CoveragePositive NewsAnalyst RevisionSMMTSummit Therapeutics3.0834 of 5 stars$26.27+0.3%$32.85+25.0%+107.8%$19.46B$700K0.00110News CoverageAnalyst ForecastOptions VolumeGap UpGMABGenmab A/S4.1844 of 5 stars$24.31-1.4%$37.60+54.7%-0.5%$15.81B$3.12B14.412,682Positive NewsVTRSViatris1.6787 of 5 stars$10.55-0.9%$10.40-1.4%-10.0%$12.42B$14.74B4.4232,000RDYDr. Reddy's Laboratories3.0347 of 5 stars$14.46-0.4%$16.95+17.3%-10.0%$12.11B$3.81B21.9927,811Positive NewsASNDAscendis Pharma A/S3.4405 of 5 stars$190.37-2.0%$243.36+27.8%+73.0%$11.89B$393.54M0.001,017News CoveragePositive NewsAnalyst ForecastQGENQIAGEN4.6645 of 5 stars$48.92-1.6%$49.69+1.6%+9.9%$11.06B$1.98B21.205,765Positive NewsMRNAModerna4.413 of 5 stars$25.35-6.5%$42.88+69.2%-65.8%$10.55B$3.24B0.005,800Options VolumeBBIOBridgeBio Pharma4.2397 of 5 stars$47.29-3.6%$61.35+29.7%+70.5%$9.38B$221.90M0.00400News CoveragePositive NewsAnalyst ForecastVRNAVerona Pharma PLC American Depositary Share2.5072 of 5 stars$105.62+0.1%$109.00+3.2%+293.3%$9.13B$42.28M0.0030News CoveragePositive News Related Companies and Tools Related Companies TEVA Alternatives SMMT Alternatives GMAB Alternatives VTRS Alternatives RDY Alternatives ASND Alternatives QGEN Alternatives MRNA Alternatives BBIO Alternatives VRNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LEGN) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredHamilton’s 100-to-1 tradePorter Stansberry has made a career out of bold calls that go against the mainstream narrative — from the 1998...Porter & Company | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
